Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bondareff, W.
Right arrow Articles by Roth, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bondareff, W.
Right arrow Articles by Roth, M.
NEUROLOGY 1982;32:164
© 1982 American Academy of Neurology

Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia

William Bondareff, Ph.D, M.D., Christopher Q. Mountjoy, M.R.C. Psych. and Martin Roth, M.D., F.R.C.P.

Ethel Percy Andrus Gerontology Center and the Department of Psychiatry and the Behavioral Sciences, University of Southern California, Los Angeles (Dr. Bondareff), and the Department of Psychiatry, University of Cambridge, Cambridge, U.K. (Drs. Mountjoy and Roth).

To examine the possibility that senile dementia may be associated with a loss of noradrenergic neurons that innervate the cerebral cortex, we used a Quantimet 720 image analyzer to estimate the number of neurons in the nucleus locus ceruleus in elderly patients with the clinical diagnosis of senile dementia. In all but one case, the diagnosis was established histopathologically as senile dementia of the Alzheimer type (SDAT). In a subgroup characterized by a high dementia score and relatively young age at death, there was a loss of about 80% of locus ceruleus neurons. This loss of neurons indicates a deficit of noradrenergic innervation to cerebral cortex in a group of patients which may represent a variant of SDAT.

Address correspondence and reprint requests to Dr. Bondareff, Ethel Percy Andrus Gerontology Center, University of Southern California, University Park, Los Angeles, CA 90007.

This study was supported by a Project Grant from the Medical Research Council. Dr. Bondareff was a Visiting Fellow of Clare Hall, University of Cambridge, on leave of absence from Northwestern University Medical School.

Accepted for publication July 2, 1981.




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
S. A. Marchitti, R. A. Deitrich, and V. Vasiliou
Neurotoxicity and Metabolism of the Catecholamine-Derived 3,4-Dihydroxyphenylacetaldehyde and 3,4-Dihydroxyphenylglycolaldehyde: The Role of Aldehyde Dehydrogenase
Pharmacol. Rev., June 1, 2007; 59(2): 125 - 150.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Z. Muresan and V. Muresan
Neuritic Deposits of Amyloid-{beta} Peptide in a Subpopulation of Central Nervous System-Derived Neuronal Cells.
Mol. Cell. Biol., July 1, 2006; 26(13): 4982 - 4997.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. Szot, S. S. White, J. L. Greenup, J. B. Leverenz, E. R. Peskind, and M. A. Raskind
Compensatory Changes in the Noradrenergic Nervous System in the Locus Ceruleus and Hippocampus of Postmortem Subjects with Alzheimer's Disease and Dementia with Lewy Bodies
J. Neurosci., January 11, 2006; 26(2): 467 - 478.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
N. Herrmann, K. L. Lanctot, and L. R. Khan
The Role of Norepinephrine in the Behavioral and Psychological Symptoms of Dementia
J Neuropsychiatry Clin Neurosci, August 1, 2004; 16(3): 261 - 276.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. M. Sharp, M. Yatsula, and Y. Fu
Effects of Galantamine, a Nicotinic Allosteric Potentiating Ligand, on Nicotine-Induced Catecholamine Release in Hippocampus and Nucleus Accumbens of Rats
J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1116 - 1123.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
K. L. Lanctôt, N. Herrmann, and P. Mazzotta
Role of Serotonin in the Behavioral and Psychological Symptoms of Dementia
J Neuropsychiatry Clin Neurosci, February 1, 2001; 13(1): 5 - 21.
[Abstract] [Full Text]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
O. Felician and T. A. Sandson
The Neurobiology and Pharmacotherapy of Alzheimer's Disease
J Neuropsychiatry Clin Neurosci, February 1, 1999; 11(1): 19 - 31.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
J. Busser, D. S. Geldmacher, and K. Herrup
Ectopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer's Disease Brain
J. Neurosci., April 15, 1998; 18(8): 2801 - 2807.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
H. C. Chui
Dementia: A Review Emphasizing Clinicopathologic Correlation and Brain-Behavior Relationships
Arch Neurol, July 1, 1989; 46(7): 806 - 814.
[Abstract] [PDF]


Home page
Arch NeurolHome page
E. Mohr, J. Schlegel, G. Fabbrini, J. Williams, M. M. Mouradian, U. M. Mann, J. J. Claus, P. Fedio, and T. N. Chase
Clonidine Treatment of Alzheimer's Disease
Arch Neurol, April 1, 1989; 46(4): 376 - 378.
[Abstract] [PDF]


Home page
Arch NeurolHome page
D. L. Sparks, S. T. DeKosky, and W. R. Markesbery
Alzheimer's Disease: Aminergic-Cholinergic Alterations in Hypothalamus
Arch Neurol, September 1, 1988; 45(9): 994 - 999.
[Abstract] [PDF]


Home page
Arch NeurolHome page
H. C. Chui, J. A. Mortimer, U. Slager, C. Zarow, W. Bondareff, and D. D. Webster
Pathologic Correlates of Dementia in Parkinson's Disease
Arch Neurol, October 1, 1986; 43(10): 991 - 995.
[Abstract] [PDF]


Home page
Arch NeurolHome page
A. D. Kay, S. Milstien, S. Kaufman, H. Creasey, J. V. Haxby, N. R. Cutler, and S. I. Rapoport
Cerebrospinal Fluid Biopterin Is Decreased in Alzheimer's Disease
Arch Neurol, October 1, 1986; 43(10): 996 - 999.
[Abstract] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
D. A. Davidoff
Issues in the clinical diagnosis of Alzheimer's disease
American Journal of Alzheimer's Disease and Other Dementias, January 1, 1986; 1(1): 9 - 15.
[Abstract] [PDF]


Home page
ScienceHome page
J. Geddes, D. Monaghan, C. Cotman, I. Lott, R. Kim, and H. Chui
Plasticity of hippocampal circuitry in Alzheimer's disease
Science, December 6, 1985; 230(4730): 1179 - 1181.
[Abstract] [PDF]


Home page
Arch NeurolHome page
C. J. Gibson, M. Logue, and J. H. Growdon
CSF Monoamine Metabolite Levels in Alzheimer's and Parkinson's Disease
Arch Neurol, May 1, 1985; 42(5): 489 - 492.
[Abstract] [PDF]


Home page
ScienceHome page
C. Kitt, D. Price, R. Struble, L. Cork, B. Wainer, M. Becher, and W. Mobley
Evidence for cholinergic neurites in senile plaques
Science, December 21, 1984; 226(4681): 1443 - 1445.
[Abstract] [PDF]


Home page
ScienceHome page
J. Coyle, D. Price, and M. DeLong
Alzheimer's disease: a disorder of cortical cholinergic innervation
Science, March 11, 1983; 219(4589): 1184 - 1190.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by AAN Enterprises, Inc.